The HPV Vaccine on Trial - Seeking Justice for a generation betrayed
Mary Holland, J.D.
Kim Mack Rosenberg, J.D.
Eileen Iorio
Preface by Dr. Luc Monagnier - Nobel Prize Winner
In 2006, following an expedited review, the Food and Drug Administration approved Merck & Co.'s Gardasil vaccine, a "preventive" vaccine targeting a limited range of strains of the human papillomavirus 9HPV), including two strains that are linked to the possible development of cervical cancers. In 2009, the FDA, in another "fast track" review, approved Cervarix, a similar vaccine by another pharmaceutical company, GlaxoSmithKline. In The HPV Vaccine, Mary Holland and Kim Mack Rosenberg, expert researchers on the making, marketing, and safety of vaccines, assess the quick popularity of the HPV vaccine. THey reveal the business behind the pharmaceutical and medical industries' push for it and how this effects the population it's most targeted toward, girls and women ages eleven to twenty-six. The insightful text is geared toward providing parents and young adults with the information they need to know to decide whether to give their children the vaccine or get it themselves.
It's also women's health organizations, health professionals, and members of the medical industry, who need to know what the effects of the vaccine on patients will be and the disturbing reasons thatthe pharmaceutical companies and the FDA released it despite disconcerting results.
ISBN: 9781510710801
Please note that purchases can not be made on this site,
but if you wish to make a purchase*
or have any queries please contact us by telephone, email
or you are very welcome to visit us at our premises.
* We endeavour to keep our
information correct, however prices and availability are subject to change.
